Thorotrast-induced cholangiocarcinoma: case report (original) (raw)

Abstract

Thorotrast, a contrast medium used extensively before being banned in 1950s, delivers a densely ionizing, high linear energy transfer type of radiation that predisposes to malignancies. We report a case of peripheral cholangiocarcinoma and describe its computed tomographic and magnetic resonance imaging features in a patient who developed it 48 years after exposure to Thorotrast.

Access this article

Log in via an institution

Subscribe and save

• Starting from 10 chapters or articles per month
• Access and download chapters and articles from more than 300k books and 2,500 journals
• Cancel anytime View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

1. Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA, , , , , , US
   D. Sahani, S. R. Prasad, P. F. Hahn, P. R. Mueller & S. Saini
2. Department of Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA, , , , , , US
   K. K. Tannabe

Authors

1. D. Sahani
2. S. R. Prasad
3. K. K. Tannabe
4. P. F. Hahn
5. P. R. Mueller
6. S. Saini

Rights and permissions

About this article

Cite this article

Sahani, D., Prasad, S., Tannabe, K. _et al._Thorotrast-induced cholangiocarcinoma: case report.Abdom Imaging 28, 0072–0074 (2003). https://doi.org/10.1007/s00261-001-0148-y

Download citation

• Issue date: January 2003
• DOI: https://doi.org/10.1007/s00261-001-0148-y